StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.28−0.12 (-1.62%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Maravai LifeSciences total assets

Total assets on the balance sheet at the end of each period.

Maravai LifeSciences's total assets was $603.75M at Jun 30, 2026. For fiscal 2025 it was $770.58M, down 23.6% from the year before. The highest annual figure on record is $2.28B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$770.58M-23.6%
FY2024Dec 31, 2024$1.01B-32.2%
FY2023Dec 31, 2023$1.49B-34.8%
FY2022Dec 31, 2022$2.28B+19.0%
FY2021Dec 31, 2021$1.92B+51.0%
FY2020Dec 31, 2020$1.27B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$603.75M-32.7%
Q1 FY2026Mar 31, 2026$713.22M-25.7%
Q4 FY2025Dec 31, 2025$770.58M-23.6%
Q3 FY2025Sep 30, 2025$849.19M-33.6%
Q2 FY2025Jun 30, 2025$896.97M-37.9%
Q1 FY2025Mar 31, 2025$959.75M-33.6%
Q4 FY2024Dec 31, 2024$1.01B-32.2%
Q3 FY2024Sep 30, 2024$1.28B-43.6%
Q2 FY2024Jun 30, 2024$1.44B-36.2%
Q1 FY2024Mar 31, 2024$1.44B-37.6%
Q4 FY2023Dec 31, 2023$1.49B-34.8%
Q3 FY2023Sep 30, 2023$2.27B+0.8%
Q2 FY2023Jun 30, 2023$2.26B+4.3%
Q1 FY2023Mar 31, 2023$2.32B+13.3%
Q4 FY2022Dec 31, 2022$2.28B+19.0%
Q3 FY2022Sep 30, 2022$2.25B+18.7%
Q2 FY2022Jun 30, 2022$2.17B+35.6%
Q1 FY2022Mar 31, 2022$2.04B+51.2%
Q4 FY2021Dec 31, 2021$1.92B+51.0%
Q3 FY2021Sep 30, 2021$1.89B–
Q2 FY2021Jun 30, 2021$1.60B–
Q1 FY2021Mar 31, 2021$1.35B–
Q4 FY2020Dec 31, 2020$1.27B–

More Maravai LifeSciences figures

See a number that looks wrong?